Phenotypic screening in drug discovery has long been revived with the expectation of providing promising guide compounds and drug targets and increasing the achievement price of drug acceptance. On the other hand, target identification continues to be a major bottleneck in phenotype-centered drug discovery. We determined the lead compounds K542 https://marcowdhlp.like-blogs.com/26394827/the-2-minute-rule-for-agx51